FDA cites Mark Cuban's drug com­pound­ing cen­ter in Dal­las with steril­i­ty, qual­i­ty con­cerns

The FDA is rais­ing steril­i­ty and oth­er qual­i­ty con­cerns with Mark Cuban’s Cost Plus Drugs com­pound­ing fa­cil­i­ty in Dal­las, fol­low­ing a nine-day in­spec­tion of the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER